Name: UMIN ID:
Unique ID issued by UMIN | UMIN000029421 |
---|---|
Receipt number | R000033623 |
Scientific Title | Randomized phase 2 trial concerning the optimum schedule of S-1 adjuvant chemotherapy for resected biliary tract cancer (TOSBIC 03) |
Date of disclosure of the study information | 2017/10/10 |
Last modified on | 2019/11/12 10:16:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/10/04 19:03:53 | ||
2 | Update | 2017/10/07 16:00:41 | Date of disclosure of the study information |
|
3 | Update | 2017/10/26 13:22:01 | Narrative objectives1 Narrative objectives1 Key secondary outcomes Key secondary outcomes |
|
4 | Update | 2017/10/26 13:28:58 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2019/11/12 10:16:04 | Recruitment status Date of IRB Last follow-up date |